publication venue for
- Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.. 26:2335-2345. 2020
- Clinical and Neuroimaging Correlates of Post-Transplant Delirium.. 26:2323-2328. 2020
- Guidelines for COVID-19 Management in Hematopoietic Cell Transplantation and Cellular Therapy Recipients.. 26:1983-1994. 2020
- Anaerobic Antibiotics and the Risk of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.. 26:2053-2060. 2020
- Securing the graft during pandemic: are we ready for cryopreservation for all?. 26:e145-e146. 2020
- Fluoroquinolone Prophylaxis in Autologous Stem Cell Transplantation: Worthy of a Second Look.. 26:e198-e201. 2020
- Unexpected Toxicities When Nivolumab Was Given as Maintenance Therapy following Allogeneic Stem Cell Transplantation.. 26:1025-1027. 2020
- Cytomegalovirus in Allogeneic Hematopoietic Transplantation: Impact on Costs and Clinical Outcomes Using a Preemptive Strategy.. 26:568-580. 2019
- Lenalidomide and Vorinostat Maintenance after Autologous Transplantation in Multiple Myeloma: Long- Term Follow-Up.. 26:44-49. 2019
- Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.. 26:189-196. 2019
- T Cell Transcriptional Profiling and Immunophenotyping Uncover LAG3 as a Potential Significant Target of Immune Modulation in Multiple Myeloma.. 26:7-15. 2019
- Assessment of Quality of Life following Allogeneic Stem Cell Transplant for Myelofibrosis.. 25:2267-2273. 2019
- Oral Vancomycin Prophylaxis as Secondary Prevention Against Clostridioides difficile Infection in the Hematopoietic Stem Cell Transplantation and Hematologic Malignancy Population.. 25:2091-2097. 2019
- BEAM versus BUCYVP16 Conditioning before Autologous Hematopoietic Stem Cell Transplant in Patients with Hodgkin Lymphoma.. 25:1107-1115. 2019
- Reduction in Mortality after Umbilical Cord Blood Transplantation in Children Over a 20-Year Period (1995-2014).. 25:756-763. 2018
- The Microbiome and Hematopoietic Cell Transplantation: Past, Present, and Future.. 24:1322-1340. 2018
- Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.. 24:726-733. 2017
- Late Gastrointestinal Complications of Allogeneic Hematopoietic Stem Cell Transplantation in Adults.. 24:734-740. 2017
- Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning.. 23:1949-1954. 2017
- Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization.. 23:1151-1157. 2017
- Reprint of: Aging: Treating the Older Patient.. 23:S10-S17. 2017
- Challenges around Access to and Cost of Life-Saving Medications after Allogeneic Hematopoietic Cell Transplantation for Medicare Patients.. 23:1387-1392. 2017
- Aging: Treating the Older Patient.. 23:193-200. 2016
- Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma.. 23:262-268. 2016
- Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis.. 22:1348-1356. 2016
- Preventing acute leukemia relapse after allogeneic transplants: how to move forward?. 19:2-3. 2013